Switch to:
More From Other Websites
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends CytRx Corp. Stockholders Vote... Sep 21 2017
CytRx Corporation Announces Amendment to Definitive Proxy Statement for Upcoming Special Meeting Sep 13 2017
CytRx Corporation Files Definitive Proxy Statement for Upcoming Special Meeting Aug 30 2017
CytRx Corporation Announces Receipt of NASDAQ Listing Determination Aug 24 2017
CytRx Corporation Files Preliminary Proxy Statement for Upcoming Special Meeting Aug 21 2017
CytRx New Drug Development Agreement Brings Cash and Experience Aug 10 2017
CytRx reports 2Q loss Aug 04 2017
CytRx Reports Second Quarter 2017 Financial Results Aug 03 2017
4 Biotech Stocks to Watch This Quarter Aug 01 2017
Today's Research Reports on Stocks to Watch: CytRx Corporation and ImmunoGen Jul 31 2017
CytRx Corporation Announces Global Strategic License With NantCell Inc. For Aldoxorubicin, An... Jul 28 2017
Penny Stocks to Watch for June 2017 (CYTR, DELT) Jun 30 2017
CytRx Announces Reshaping of Clinical and Regulatory Executive Team Jun 13 2017
Today's Research Reports on Stocks to Watch: CytRx and Hydrogenics Corporation Jun 09 2017
CytRx Announces Update on the Regulatory Pathway for Aldoxorubicin in Soft Tissue Sarcomas Jun 08 2017
Goodbye CytRx, Your Game Is Over Jun 05 2017
Penny Stocks to Watch for June 2017 May 31 2017
Today's Research Reports on Stocks to Watch: Endocyte and CytRx May 31 2017
The Most Notable Abstracts Released Ahead Of ASCO 2017 May 19 2017
Today's Research Reports on Biotech Stocks to Watch: Achillion Pharmaceuticals and CytRx May 19 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK